Earnshaw C J, Pecaric-Petkovic T, Park B K, Naisbitt D J
Department of Molecular and Clinical Pharmacology, Medical Research Council Centre for Drug Safety Science, University of Liverpool, Sherrington Building, Ahston Street, Liverpool, L69 3GE, UK,
Exp Suppl. 2014;104:137-63. doi: 10.1007/978-3-0348-0726-5_10.
Understanding the chemical mechanisms by which drugs and drug metabolites interact with cells of the immune system is pivotal to our knowledge of drug hypersensitivity as a whole.In this chapter, we will discuss the currently accepted mechanisms where there is scientific and clinical evidence to support the ways in which drugs and their metabolites interact with T cells. We will also discuss bioanalytical platforms, such as mass spectrometry, and in vitro test assays such as the lymphocyte transformation test that can be used to study drug hypersensitivity; the combination of such techniques can be used to relate the chemistry of drug antigen formation to immune function. Ab initio T cell priming assays are also discussed with respect to predicting the potential of a drug to cause hypersensitivity reactions in humans in relation to the chemistry of the drug and its ability to form haptens, antigens and immunogens in patients.
了解药物及其代谢产物与免疫系统细胞相互作用的化学机制,对于我们全面认识药物超敏反应至关重要。在本章中,我们将讨论目前已被认可的机制,这些机制有科学和临床证据支持药物及其代谢产物与T细胞相互作用的方式。我们还将讨论生物分析平台,如质谱分析法,以及体外测试分析方法,如淋巴细胞转化试验,这些可用于研究药物超敏反应;此类技术的结合可用于将药物抗原形成的化学过程与免疫功能联系起来。还将讨论从头开始的T细胞致敏分析,以预测药物相对于其化学性质及其在患者体内形成半抗原、抗原和免疫原的能力,在人类中引起超敏反应的可能性。